{"id":16976,"date":"2014-07-29T09:31:35","date_gmt":"2014-07-29T09:31:35","guid":{"rendered":"https:\/\/nexplasmagen.com\/home-bridge-health\/"},"modified":"2025-12-29T18:11:48","modified_gmt":"2025-12-29T18:11:48","slug":"home-bridge-health","status":"publish","type":"page","link":"https:\/\/nexplasmagen.com\/fr\/","title":{"rendered":"Accueil"},"content":{"rendered":"

[vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb background_color=\u00a0\u00bb#ffffff\u00a0\u00bb][vc_column][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb90″ padding_bottom=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]<\/p>\n

LES FAITS<\/h2>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbnormal\u00a0\u00bb transparency=\u00a0\u00bb1″ thickness=\u00a0\u00bb4″][vc_column_text]<\/p>\n

Th\u00e9rapie conservatrice du sein (BCT)<\/strong><\/span><\/h3>\n

 <\/p>\n

Dans le monde entier, plus d’un million de femmes, chez qui un cancer du sein a \u00e9t\u00e9 diagnostiqu\u00e9, subissent chaque ann\u00e9e une BCT (chirurgie avec radioth\u00e9rapie de suivi) comme alternative \u00e0 la mastectomie, les deux proc\u00e9dures ayant un taux de survie comparable pour les cancers du sein pr\u00e9coces.<\/a><\/span><\/span>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_empty_space height=\u00a0\u00bb64px\u00a0\u00bb][vc_column_text]<\/p>\n

R\u00e9cidive des BCT<\/strong><\/span><\/h3>\n

 <\/p>\n

La norme actuelle de soins recommandant la BCT souffre d’un taux de r\u00e9cidive de 15% dans les 10 ans<\/a> en raison d’une marge positive <\/span><\/a>(cellules canc\u00e9reuses r\u00e9siduelles dans le lit tumoral apr\u00e8s que la tumeur solide est retir\u00e9e).<\/span>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_empty_space height=\u00a0\u00bb64px\u00a0\u00bb][vc_column_text]<\/p>\n

Survivre au cancer du sein<\/strong><\/span><\/h3>\n

 <\/p>\n

Les risques r\u00e9siduels de r\u00e9cidive \u00e0 5 ans pour les patients atteints de cancers du sein de stade I, II, III et IV sont d’environ 7 %, 11 %, 13 % et >20<\/a><\/span> % respectivement, ce qui correspond \u00e0 des taux de survie \u00e0 5 ans de 100 %, 93 %, 72 % et 22<\/a> %<\/span> respectivement.<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_type=\u00a0\u00bbparallax\u00a0\u00bb parallax_content_width=\u00a0\u00bbin_grid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb full_screen_section_height=\u00a0\u00bbno\u00a0\u00bb background_image=\u00a0\u00bb15881″ section_height=\u00a0\u00bb450″][vc_column][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb text_align=\u00a0\u00bbcenter\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1638465860181{padding-top: 100px !important;}\u00a0\u00bb][vc_column_inner width=\u00a0\u00bb1\/4″]

10<\/span>

Nombre d\u2019articles scientifiques \u00e9valu\u00e9s par des pairs<\/p><\/div>[vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb20″ down=\u00a0\u00bb0″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/4″]

9<\/span>

Nombre de projets compl\u00e9t\u00e9s<\/p><\/div>[vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb20″ down=\u00a0\u00bb0″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/4″]

2<\/span>

Nombre de brevets et brevets d\u00e9pos\u00e9s<\/p><\/div>[vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb20″ down=\u00a0\u00bb0″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/4″]

27<\/span>

Nombre de conf\u00e9rences<\/p><\/div>[vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb155″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner][vc_column_text]<\/p>\n

\u00c9QUIPE<\/strong><\/h2>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb16921″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]Val\u00e9rie L\u00e9veill\u00e9, ing., M. ing., PhD<\/strong><\/span><\/p>\n

CEO<\/strong><\/span><\/p>\n

\u00a0<\/strong><\/span><\/h6>\n
CEO \/ Founder
\n<\/strong><\/span><\/h6>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb]Val\u00e9rie a 16 ans d’exp\u00e9rience en R&D, conception et commercialisation de technologies. Elle est co-inventeur de la technologie de NexPlasmaGenMC<\/sup>.<\/span>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb16922″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_right\u00a0\u00bb transition_delay=\u00a0\u00bb2″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]Audrey Glory, PhD \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><\/span><\/p>\n

Leader, essais pr\u00e9cliniques<\/strong><\/span>[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][vc_column_text]Audrey a 5 ans d’exp\u00e9rience dans la conduite d’essais pr\u00e9cliniques pour le cancer du sein et d’autres cancers. Elle travaille chez NexPlasmaGen et au CR-CHUM.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb65″][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb16923″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]Philip Wong, MDCM, MSc, FRCPC<\/strong><\/span><\/p>\n

Aviseur M\u00e9dical<\/strong><\/span>[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][vc_column_text]Philip est professeur adjoint au d\u00e9partement de radio-oncologie de l’Universit\u00e9 de Toronto. Il est clinicien-chercheur au CR-CHUM. Il dirige le programme clinique de NexPlasmaGen et est co-inventeur de la technologie de NexPlasmaGen.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb16924″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_right\u00a0\u00bb transition_delay=\u00a0\u00bb2″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]Julie Lafontaine, PhD \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/span><\/p>\n

Superviseure de laboratoire, CR-CHUM<\/strong><\/span>[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][vc_column_text]Julie a 7 ans d’exp\u00e9rience dans la supervision du laboratoire du Dr Wong et joue un r\u00f4le crucial dans les essais pr\u00e9cliniques du NexPlasmaGen. Elle travaille au CR-CHUM.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner][vc_column_text]CONSEIL D\u2019ADMINISTRATION<\/strong><\/span>[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb16921″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb]Val\u00e9rie L\u00e9veill\u00e9, ing., M. ing., PhD <\/strong><\/span><\/p>\n

Pr\u00e9sidente et Membre du conseil d\u2019administration<\/strong><\/span>[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb17242″ img_size=\u00a0\u00bbfull\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb]David Uffer<\/strong><\/p>\n

MBA, B.A.<\/strong><\/p>\n

Directeur g\u00e9n\u00e9ral de MedTech chez Trinity Life Sciences<\/p>\n

Avant: Directeur BD de Covidien, Hologic Inc. Boston Scientific, et VP BD, Bovie Medical<\/p>\n

30 ans de commercialization de dispositifs m\u00e9dicaux[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb17312″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] Suman Mallick, BS, MBA, MFA<\/strong><\/p>\n

Directeur g\u00e9n\u00e9ral chez Keystone National Group<\/p>\n

Ange Investisseur chez SWAN (Southwest Angel Network).<\/p>\n

Pass\u00e9 : Directeur g\u00e9n\u00e9ral chez Revere Capital, gestion des risques de cr\u00e9dit et march\u00e9s de capitaux chez Skills Fund.<\/p>\n

Plusieurs r\u00f4les professionnels d’investissement chez Fortress Investment Group et Citi.<\/p>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner][vc_column_text]<\/p>\n

COMIT\u00c9 AVISEUR SCIENTIFIQUE<\/strong><\/h2>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][vc_separator type=\u00a0\u00bbfull_width\u00a0\u00bb thickness=\u00a0\u00bb5″][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb16923″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]Philip Wong<\/strong><\/p>\n

MD, MSc, MDCM, FRCPC<\/strong><\/p>\n

Professeur agr\u00e9g\u00e9,<\/p>\n

D\u00e9partement de radio-oncologie, Universit\u00e9 de Toronto<\/p>\n

Clinicien-investigateur-Centre du cancer Princess Margaret[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb17119″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]Erica Patocskai<\/strong><\/p>\n

MD, FRCSC<\/strong><\/p>\n

Chef, service de chirurgie oncologique, CHUM<\/p>\n

Professeure clinique agr\u00e9g\u00e9e,<\/p>\n

D\u00e9partement de chirurgie, Facult\u00e9 de m\u00e9decine, Universit\u00e9 de Montr\u00e9al[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb17157″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]Jean-Fran\u00e7ois Lapointe<\/strong><\/p>\n

Ph.D.<\/strong><\/p>\n

Consultant, Affaires cliniques et r\u00e9glementaires<\/p>\n

Lok North-America[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner][vc_column_text]<\/p>\n

COMIT\u00c9 AVISEUR D’AFFAIRES<\/strong><\/h2>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb17242″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb]David Uffer<\/strong><\/p>\n

MBA, B.A.<\/strong><\/p>\n

Directeur g\u00e9n\u00e9ral de MedTech chez Trinity Life Sciences<\/p>\n

Avant: Directeur BD de Covidien, Hologic, Boston Scientific et VP BD, Bovie Medical<\/p>\n

30 ans de commercialization de dispositifs m\u00e9dicaux[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb17317″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text]Sohaib Siddiqui<\/strong><\/p>\n

B.ScH, MD, FRCSI \u00a0<\/strong><\/p>\n

EIR @ TIAP et \u00e0 la facult\u00e9 de m\u00e9decine<\/p>\n

Boursier en innovation, h\u00f4pital Women\u2019s College<\/p>\n

Associ\u00e9, Kettlebeck Ventures[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb17267″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb]Edward J. Dougherty<\/strong><\/p>\n

B.A., M.S., Th.M.<\/strong><\/p>\n

Principal chez <\/span>dougherty.consulting, llc<\/b><\/b><\/p>\n

30 ans d\u2019exp\u00e9rience en r\u00e9glementation et remboursement des dispositifs m\u00e9dicaux<\/p>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/6″][vc_single_image image=\u00a0\u00bb17269″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb css=\u00a0\u00bb\u00a0\u00bb qode_css_animation=\u00a0\u00bbelement_from_left\u00a0\u00bb transition_delay=\u00a0\u00bb1″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text css=\u00a0\u00bb\u00a0\u00bb]<\/p>\n

Samuel Ohayon<\/b><\/b><\/p>\n

B.S., M.S.<\/strong><\/p>\n

Entrepreneur en r\u00e9sidence chez CTS<\/b><\/b><\/span><\/p>\n

Partenaire en capital-risque pour des fonds en technologies de la sant\u00e9<\/p>\n

Cadre en technologies de la sant\u00e9<\/p>\n

Entrepreneur en biotechnologie<\/p>\n

Form\u00e9 en pathologie mol\u00e9culaire<\/p>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb3″ down=\u00a0\u00bb0″][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb background_color=\u00a0\u00bb#f9f9f9″][vc_column][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb55″ padding_bottom=\u00a0\u00bb55″][vc_column_inner][vc_column_text]<\/p>\n

D\u00e9couvrez nos partenaires qui soutiennent notre entreprise et le d\u00e9veloppement de notre technologie<\/h2>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb-10″ padding_bottom=\u00a0\u00bb55″][vc_column_inner width=\u00a0\u00bb1\/2″][vc_single_image image=\u00a0\u00bb16981″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/2″][vc_column_text]<\/p>\n

R\u00e9alis\u00e9 en partie gr\u00e2ce aux services-conseils et au financement du Programme d\u2019aide \u00e0 la\u00a0 recherche industrielle du Conseil national de recherches du Canada (PARI CNRC)\u00a0<\/em><\/span><\/h6>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb0″ padding_bottom=\u00a0\u00bb55″][vc_column_inner width=\u00a0\u00bb1\/4″][vc_single_image image=\u00a0\u00bb16961″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/4″][vc_single_image image=\u00a0\u00bb16960″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/4″][vc_single_image image=\u00a0\u00bb16959″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/4″][vc_single_image image=\u00a0\u00bb17217″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb0″ padding_bottom=\u00a0\u00bb55″][vc_column_inner width=\u00a0\u00bb1\/3″][vc_single_image image=\u00a0\u00bb16963″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_single_image image=\u00a0\u00bb16983″ img_size=\u00a0\u00bblarge\u00a0\u00bb onclick=\u00a0\u00bbcustom_link\u00a0\u00bb img_link_target=\u00a0\u00bb_blank\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb link=\u00a0\u00bbhttps:\/\/www.medteq.ca\/\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_single_image image=\u00a0\u00bb16962″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb0″ padding_bottom=\u00a0\u00bb55″][vc_column_inner width=\u00a0\u00bb1\/3″][vc_single_image image=\u00a0\u00bb17137″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_single_image image=\u00a0\u00bb17135″ img_size=\u00a0\u00bblarge\u00a0\u00bb onclick=\u00a0\u00bbcustom_link\u00a0\u00bb img_link_target=\u00a0\u00bb_blank\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb link=\u00a0\u00bbhttps:\/\/www.medteq.ca\/\u00a0\u00bb][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][vc_single_image image=\u00a0\u00bb17133″ img_size=\u00a0\u00bblarge\u00a0\u00bb qode_css_animation=\u00a0\u00bb\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb up=\u00a0\u00bb55″ down=\u00a0\u00bb0″][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb background_color=\u00a0\u00bb#353535″][vc_column][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb55″][vc_column_inner][vc_column_text]<\/p>\n

Vous avez rencontr\u00e9 l’\u00e9quipe, d\u00e9couvrez maintenant notre technologie!<\/span><\/h2>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbcenter\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb40″ padding_bottom=\u00a0\u00bb60″][vc_column_inner width=\u00a0\u00bb1\/3″][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″]TECHNOLOGIE<\/a>[\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/3″][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb background_color=\u00a0\u00bb#ffffff\u00a0\u00bb][vc_column][vc_row_inner row_type=\u00a0\u00bbrow\u00a0\u00bb type=\u00a0\u00bbgrid\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb css_animation=\u00a0\u00bb\u00a0\u00bb padding_top=\u00a0\u00bb90″ padding_bottom=\u00a0\u00bb75″][vc_column_inner width=\u00a0\u00bb1\/3″][vc_column_text] LES FAITS [\/vc_column_text][vc_separator type=\u00a0\u00bbnormal\u00a0\u00bb transparency=\u00a0\u00bb1″ thickness=\u00a0\u00bb4″][vc_column_text] Th\u00e9rapie conservatrice du sein (BCT)   Dans le monde entier, plus d’un million de femmes, chez qui un cancer du sein a \u00e9t\u00e9…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"class_list":["post-16976","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nexplasmagen.com\/fr\/wp-json\/wp\/v2\/pages\/16976"}],"collection":[{"href":"https:\/\/nexplasmagen.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nexplasmagen.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nexplasmagen.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nexplasmagen.com\/fr\/wp-json\/wp\/v2\/comments?post=16976"}],"version-history":[{"count":23,"href":"https:\/\/nexplasmagen.com\/fr\/wp-json\/wp\/v2\/pages\/16976\/revisions"}],"predecessor-version":[{"id":17318,"href":"https:\/\/nexplasmagen.com\/fr\/wp-json\/wp\/v2\/pages\/16976\/revisions\/17318"}],"wp:attachment":[{"href":"https:\/\/nexplasmagen.com\/fr\/wp-json\/wp\/v2\/media?parent=16976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}